KRYS financials
Krystal Biotech (KRYS) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
KRYS income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $389.13M | $360.36M | $161.29M | $204.83M | 6.84 |
| 2024 | $290.51M | $270.45M | $65.69M | $89.16M | 3.00 |
| 2023 | $50.70M | $47.60M | -$109.73M | $10.93M | 0.39 |
| 2022 | $0.00 | $0.00 | -$145.20M | -$139.97M | -5.49 |
| 2021 | $0.00 | $0.00 | -$68.28M | -$69.57M | -3.13 |
| 2020 | $0.00 | -$1.85M | -$33.00M | -$32.17M | -1.71 |
- KRYS revenue was $389.13M in fiscal 2025, net income $204.83M.
Updated 2026-11-02 17:55 UTC